{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:38:38Z","timestamp":1793367518481,"version":"4.5.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK133177"],"award-info":[{"award-number":["R01DK133177"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK133177"],"award-info":[{"award-number":["R01DK133177"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Biological heterogeneity in critical illness syndromes, such as sepsis and acute kidney injury (AKI), has hindered development of effective therapies. In sepsis-associated AKI, two molecular subphenotypes (SP1 and SP2) have been identified with differing characteristics, outcomes, and response to vasopressor treatment. It is unknown if these subphenotypes extend to all patients with sepsis and whether they respond differently to fluid resuscitation strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients enrolled in the CLOVERS clinical trial with plasma collected at study enrollment were classified into two subphenotypes using a previously validated parsimonious prediction model that included angiopoietin-1 and -2 and soluble tumor necrosis factor receptor-1. Kaplan-Meier estimates were used to test differences in outcomes and subphenotype by treatment interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Among 1,289 patients, we identified 1,016 as SP1 and 273 as SP2. The risk of poor clinical outcomes was greater in SP2 than in SP1 independent of demographics, comorbidities, and illness severity scores. Patients with SP2, characterized by more severe endothelial injury and inflammation, had higher 28-day mortality with a liberal versus restrictive fluid strategy (41% vs. 27%), whereas patients with SP1 had no difference (9% vs. 9%) (P value for interaction\u2009=\u20090.02). Furthermore, SP2 had fewer days free from ventilation, renal replacement therapy, and vasopressors with a liberal compared with a restrictive resuscitation strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Molecular subphenotypes previously identified in AKI are also identifiable in sepsis and respond differently to fluid resuscitation strategy. Future prospective identification of these subphenotypes could inform a precision-guided therapeutic approach in sepsis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202412-2377oc","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T17:37:08Z","timestamp":1752687428000},"page":"1681-1688","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":23,"title":["Molecular Phenotyping of Sepsis and Differential Response to Fluid Resuscitation"],"prefix":"10.1093","volume":"211","author":[{"given":"Elizabeth","family":"Kiernan","sequence":"first","affiliation":[{"name":"Kidney Research Institute, Division of Nephrology, Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila R.","family":"Zelnick","sequence":"additional","affiliation":[{"name":"Kidney Research Institute, Division of Nephrology, Department of Medicine"},{"name":"Sepsis Center of Research Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4940-0386","authenticated-orcid":false,"given":"Ayesha","family":"Khader","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-4459","authenticated-orcid":false,"given":"Taylor D.","family":"Coston","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoie A.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Speckmaier","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Lo","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward D.","family":"Siew","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9072-0559","authenticated-orcid":false,"given":"Neha A.","family":"Sathe","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R.","family":"Kestenbaum","sequence":"additional","affiliation":[{"name":"Sepsis Center of Research Excellence"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Mount Sinai Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-0591","authenticated-orcid":false,"given":"Nicholas J.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"},{"name":"Department of Emergency Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivor S.","family":"Douglas","sequence":"additional","affiliation":[{"name":"Pulmonary Science and Critical Care Medicine, Denver Health Medical Center, University of Colorado Anschutz Medical Campus, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hough","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan K.","family":"Bhatraju","sequence":"additional","affiliation":[{"name":"Kidney Research Institute, Division of Nephrology, Department of Medicine"},{"name":"Sepsis Center of Research Excellence"},{"name":"Division of Pulmonary, Critical Care and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"2026011723324300400_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"2026011723324300400_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13054-017-1807-x","article-title":"Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype","volume":"21","author":"Bhatraju","year":"2017","journal-title":"Crit Care"},{"key":"2026011723324300400_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.201505-0995OC","article-title":"The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock","volume":"193","author":"Kellum","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026011723324300400_bib4","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"key":"2026011723324300400_bib5","article-title":"Acute kidney injury","author":"KDIGO"},{"key":"2026011723324300400_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","article-title":"From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU","volume":"210","author":"Gordon","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026011723324300400_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1164\/rccm.201807-1346OC","article-title":"Identification of acute kidney injury sub-phenotypes with differing molecular signatures and response to vasopressin therapy","volume":"199","author":"Bhatraju","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026011723324300400_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cyto.2011.04.005","article-title":"Acute administration of recombinant angiopoietin-1 ameliorates multiple-organ dysfunction syndrome and improves survival in murine sepsis","volume":"55","author":"David","year":"2011","journal-title":"Cytokine"},{"key":"2026011723324300400_bib9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1128\/MCB.01472-08","article-title":"Angiopoietin 2 is a partial agonist\/antagonist of Tie2 signaling in the endothelium","volume":"29","author":"Yuan","year":"2009","journal-title":"Mol Cell Biol"},{"key":"2026011723324300400_bib10","doi-asserted-by":"crossref","first-page":"335ra55","DOI":"10.1126\/scitranslmed.aad9260","article-title":"Amelioration of sepsis by TIE2 activation-induced vascular protection","volume":"8","author":"Han","year":"2016","journal-title":"Sci Transl Med"},{"key":"2026011723324300400_bib11","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pmed.0030046","article-title":"Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans","volume":"3","author":"Parikh","year":"2006","journal-title":"PLoS Med"},{"key":"2026011723324300400_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ki.2013.286","article-title":"TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis","volume":"85","author":"Xu","year":"2014","journal-title":"Kidney Int"},{"key":"2026011723324300400_bib13","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2215\/CJN.04100318","article-title":"A prediction model for severe AKI in critically ill adults that incorporates clinical and biomarker data","volume":"14","author":"Bhatraju","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011723324300400_bib14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"2026011723324300400_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026011723324300400_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026011723324300400_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"2026011723324300400_bib18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/rccm.202308-1448LE","article-title":"The interaction of acute kidney injury with resuscitation strategy in sepsis: a secondary analysis of a multicenter, phase 3, randomized trial (CLOVERS)","volume":"208","author":"Khader","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"10 Suppl","key":"2026011723324300400_bib19","article-title":"Molecular phenotyping of patients with sepsis and kidney injury and differential response to fluid therapy: secondary analysis of a clinical trial [abstract]","volume":"35","author":"Kiernan","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2026011723324300400_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026011723324300400_bib21","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why test for proportional hazards?","volume":"323","author":"Stensrud","year":"2020","journal-title":"JAMA"},{"key":"2026011723324300400_bib22","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","article-title":"Redefining critical illness","volume":"28","author":"Maslove","year":"2022","journal-title":"Nat Med"},{"key":"2026011723324300400_bib23","first-page":"536","volume-title":"Kidney Int","author":"Siew","year":"2010"},{"key":"2026011723324300400_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2008.11.030","article-title":"Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation","volume":"53","author":"David","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026011723324300400_bib25","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/cc6966","article-title":"Circulating angiopoietin-1 and angiopoietin-2 in critically ill patients: development and clinical application of two new immunoassays","volume":"12","author":"Lukasz","year":"2008","journal-title":"Crit Care"},{"key":"2026011723324300400_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12882-020-01935-1","article-title":"Genetic variation implicates plasma angiopoietin-2 in the development of acute kidney injury sub-phenotypes","volume":"21","author":"Bhatraju","year":"2020","journal-title":"BMC Nephrol"},{"key":"2026011723324300400_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2215\/CJN.0000000000000389","article-title":"Associations of angiopoietin 2 and vascular endothelial growth factor-A concentrations with clinical end points","volume":"19","author":"Mohebi","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026011723324300400_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1681\/ASN.2013050542","article-title":"Angiopoietin-2-induced arterial stiffness in CKD","volume":"25","author":"Chang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2026011723324300400_bib29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2021060757","article-title":"Angiopoietins as prognostic markers for future kidney disease and heart failure events after acute kidney injury","volume":"33","author":"Mansour","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2026011723324300400_bib30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int"},{"key":"2026011723324300400_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13054-024-04875-6","article-title":"Vascular leak in sepsis: physiological basis and potential therapeutic advances","volume":"28","author":"McMullan","year":"2024","journal-title":"Crit Care"},{"key":"2026011723324300400_bib32","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1038\/s41598-024-55667-5","article-title":"Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial","volume":"14","author":"DeMerle","year":"2024","journal-title":"Sci Rep"},{"key":"2026011723324300400_bib33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40635-022-00435-w","article-title":"Towards a biological definition of ARDS: are treatable traits the solution?","volume":"10","author":"Bos","year":"2022","journal-title":"Intensive Care Med Exp"},{"key":"2026011723324300400_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ekir.2020.10.010","article-title":"Phase-3 randomized controlled trials on exclusion of participants with kidney disease in COVID-19","volume":"6","author":"Chewcharat","year":"2021","journal-title":"Kidney Int Rep"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/211\/9\/1681\/66439861\/ajrccm_211_9_1681.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/211\/9\/1681\/66439861\/ajrccm_211_9_1681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T04:33:11Z","timestamp":1768710791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/211\/9\/1681\/8300639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,1]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202412-2377oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"2024-12-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}